Results 211 to 220 of about 3,996,783 (390)

The role of intra‐abdominal pressure and point of care ultrasound to guide decongestive therapies in acute heart failure

ESC Heart Failure, EarlyView.
The ABDOPOCUS‐HF trial is a randomized, single‐blind, low‐intervention clinical trial (n = 168) investigating the utility of intra‐abdominal pressure (IAP) and point of care ultrasound to guide decongestive therapies during the first 72 hours after admission for acute heart failure.
C. Josa‐Laorden, A. Campos‐Saenz de Santamaría, S. Crespo‐Aznarez, J. Pérez‐Silvestre, E. Montero‐Hernandez, P. Llacer‐Iborra, J. Torres‐Macho, M. Méndez‐Bailon, J.L. Morales‐Rull, P. Salamanca‐Bautista, N. Fernández‐Villa, I. Torres‐Courchoud, M.A. Vázquez‐Ronda, R. Martínez‐Gutiérrez, P. Serrano‐Irigoyen, N. García‐Lorente, J.C. Trullas, M. Cobo‐Marcos, M.J. Pinilla, M. Sánchez‐Marteles, J. Rubio‐Gracia   +20 more
wiley   +1 more source

The Psychological Relieving Effect of Drug Provocation Test in Drug Hypersensitivity. [PDF]

J Asthma Allergy, 2022
Rhyou HI, Nam YH.
europepmc   +1 more source

Remote pulmonary artery pressure‐guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

European Journal of Heart Failure, EarlyView.
Abstract Episodes of worsening heart failure (HF) are a major cause of unplanned hospitalizations. Their onset is usually preceded by an early increase in intracardiac pressures with subsequent worsening of symptoms due to congestion. Implantable devices allowing daily remote pulmonary artery pressure (PAP) monitoring are useful to identify early ...
Antoni Bayes‐Genis, Matteo Pagnesi, Pau Codina, William T. Abraham, Offer Amir, Rudolf A. de Boer, Jasper J. Brugts, Ovidiu Chioncel, Finn Gustafsson, JoAnn Lindenfeld, Wilfried Mullens, Mark C. Petrie, Giuseppe Rosano, Marco Metra   +13 more
wiley   +1 more source

Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines. [PDF]

Allergy, 2022
Palomares F, Paris JL, Labella M, Doña I, Mayorga C, Torres MJ.   +5 more
europepmc   +1 more source

A Perspective on the Challenges and Issues in Developing Biomarkers for Human Allergic Risk Assessments [PDF]

, 2017
Godar, Dianne E., Merrill, Stephen, Mu, Ying   +2 more
core   +2 more sources

Late‐onset asystole associated with vagal nerve stimulation

Epilepsia Open, EarlyView.
Abstract Vagal nerve stimulation (VNS) is a form of neuromodulation that is an established adjunct in the management of drug‐resistant epilepsy. The common side effects of VNS are cough, dysphonia, or shortness of breath, which are often mild and do not require discontinuation of therapy.
Divya Nagabushana, Huan Huynh, Mark D. McCauley, Anna Serafini   +3 more
wiley   +1 more source

Drug hypersensitivity syndrome induced by sulfasalazine: A case report. [PDF]

Medicine (Baltimore), 2022
Chen DH, Zhou HR, Zhang YG, Shen GY, Xu C, Guan CL.   +5 more
europepmc   +1 more source

DRUG HYPERSENSITIVITY AND ADVERSE REACTION IN CHILDRTEN

, 1995
Kazuhiro Sasamoto, Takashi Mishima, Yoji Iíkura   +2 more
openalex   +2 more sources

Testing for hypersensitivity reactions to intravenous drug and biologic agents: Recommendations in product labels [PDF]

, 2005
H KO
openalex   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

Epilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang, Emilio Perucca, Samuel F. Berkovic, Piero Perucca   +3 more
wiley   +1 more source